Since mouse Aβ is less toxic than human’s, it may also be important to cross eNOS-deficient mice with AD mice expressing human FAD APP mutants to study interplay between chronic hypoperfusion and amyloid progression. This evidence concerns the gene APP and Alzheimer disease.